About Index Trending news
Analyze
Top 50 Pricing
Apellis Pharma

Apellis Pharma

Work at Apellis Pharma? Add yourself to this profile

Apellis Pharma

Small Biotech Focusing on Complement Immunotherapy

Elsewhere

Alexa global traffic share

Twitter followers

12 Feb 2016
$47,100,000
Venture capital (Series D)
Hillhouse Capital Group, Epidarex Capital, Cormorant Asset Management, +3

Apellis Pharmaceuticals Completes $47.1M Series D Financing

FinSMEs
07 Jan 2016
$32,000,000
Venture capital (Series D)

Apellis Pharma Accepts $32 Million Equity VC

venturedeal